These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8552761

  • 61. Effects of antifungal pretreatment on the susceptibility of Candida albicans to human leukocytes.
    Mínguez Mínguez F, Lima JE, García MT, Prieto J.
    Chemotherapy; 1997; 43(5):346-51. PubMed ID: 9309368
    [Abstract] [Full Text] [Related]

  • 62. [Establishment and evaluation of microdilution assays for the in vitro sensitivity testing of Aspergillus fumigatus].
    Schmidt A, Schmidt DI.
    Arzneimittelforschung; 2000 May; 50(5):495-501. PubMed ID: 10858878
    [Abstract] [Full Text] [Related]

  • 63. Impact of pH on the antifungal susceptibility of vaginal Candida albicans.
    Liu W, Zhang X, Liu Z, Luo X.
    Int J Gynaecol Obstet; 2011 Sep; 114(3):278-80. PubMed ID: 21696733
    [Abstract] [Full Text] [Related]

  • 64. Malassezia species: the need to establish epidemiological cutoff values.
    Rojas FD, Sosa MLÁ, Latorre W, Mussin J, Alegre L, Giusiano G.
    Med Mycol; 2022 Aug 08; 60(8):. PubMed ID: 35772016
    [Abstract] [Full Text] [Related]

  • 65. [Sensitivity test to antifungal agents: results relative to 150 strains of yeasts].
    Gullace R, Piccirillo MM, Cirella M, Ravier G, Di Girolamo F.
    Quad Sclavo Diagn; 1984 Dec 08; 20(4):451-9. PubMed ID: 6399581
    [Abstract] [Full Text] [Related]

  • 66. Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect.
    Hope WW, Warn PA, Sharp A, Howard S, Kasai M, Louie A, Walsh TJ, Drusano GL, Denning DW.
    Antimicrob Agents Chemother; 2006 Nov 08; 50(11):3680-8. PubMed ID: 16954320
    [Abstract] [Full Text] [Related]

  • 67. Quantitative screening for fluconazole-amphotericin B antagonism in several Candida albicans strains by a comparative agar diffusion assay.
    Scheven M, Scheven C.
    Mycoses; 1996 Nov 08; 39(3-4):111-4. PubMed ID: 8767003
    [Abstract] [Full Text] [Related]

  • 68. In vitro assessment of antifungal drug resistance.
    Holmberg K.
    Acta Derm Venereol Suppl (Stockh); 1986 Nov 08; 121():131-8. PubMed ID: 3459340
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. In vitro susceptibility testing of Fonsecaea pedrosoi to antifungals.
    de Bedout C, Gómez BL, Restrepo A.
    Rev Inst Med Trop Sao Paulo; 1997 Nov 08; 39(3):145-8. PubMed ID: 9460254
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. In vitro combination of antifungal agents against Malassezia pachydermatis.
    Schlemmer KB, de Jesus FPK, Loreto ES, Farias JB, Alves SH, Ferreiro L, Santurio JM.
    Med Mycol; 2019 Apr 01; 57(3):324-327. PubMed ID: 29924372
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Correlation of in vitro and in vivo susceptibility of Candida albicans to amphotericin B and natamycin.
    O'Day DM, Ray WA, Robinson RD, Head WS.
    Invest Ophthalmol Vis Sci; 1987 Mar 01; 28(3):596-603. PubMed ID: 3549613
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.